THE INVESTIGATIONAL DRUG BREMELANOTIDE FOR HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD): EFFICACY ANALYSES FROM THE RECONNECT STUDIES

被引：0
|
作者：
Clayton, A. H. [1 ]
Kingsberg, S. A. [2 ]
Simon, J. [3 ,4 ]
Jordan, R. [5 ]
Lucas, J. [5 ]
机构：
[1] Univ Virginia, Charlottesville, VA USA
[2] Univ Hosp Case Med Ctr, Cleveland, OH USA
[3] Washington Univ, Washington, DC USA
[4] Womens Hlth & Res Consultants, Washington, DC USA
[5] Palatin Technol Inc, Cranbury, NJ USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2018年 / 15卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
014
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [1] BREMELANOTIDE (BMT) FOR HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD): EFFICACY ANALYSES FROM THE RECONNECT STUDIES
    Clayton, A. H.
    Kingsberg, S. A.
    Simon, J.
    Jordan, R.
    Lucas, J.
    JOURNAL OF SEXUAL MEDICINE, 2018, 15 (07): : S125 - S126
  • [2] BREMELANOTIDE (BMT) FOR HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) IN THE RECONNECT STUDY: EFFICACY ANALYSES IN STUDY COMPLETERS AND RESPONDERS
    Simon, J.
    Portman, D.
    Kingsberg, S.
    Clayton, A.
    Jordan, R.
    Lucas, J.
    Spana, C.
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (06): : E356 - E357
  • [3] Bremelanotide for Hypoactive Sexual Desire Disorder: Age and Weight Subgroup Efficacy Analyses ( Reconnect Studies)
    Simon, James
    Kingsberg, Sheryl
    Clayton, Anita
    Jordan, Robert
    Lucas, Johna
    JOURNAL OF WOMENS HEALTH, 2018, 27 (04) : 4 - 5
  • [4] BREMELANOTIDE FOR HYPOACTIVE SEXUAL DESIRE DISORDER: AGE AND WEIGHT SUBGROUP EFFICACY ANALYSES (RECONNECT STUDIES)
    Simon, J.
    Kingsberg, S.
    Clayton, A.
    Jordan, R.
    Lucas, J.
    JOURNAL OF SEXUAL MEDICINE, 2019, 16 (04): : S105 - S106
  • [5] EFFICACY OF BREMELANOTIDE FOR HYPOACTIVE SEXUAL DESIRE DISORDER (RECONNECT STUDY)
    Kingsberg, Sheryl
    Lucas, John
    Jordan, Robert
    Spana, Carl
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (05): : E335 - E335
  • [6] Elements of desire questionnaire assessment of bremelanotide efficacy for hypoactive sexual desire disorder in the reconnect studies
    Clayton, A.
    Althof, S.
    DeRogatis, L.
    Kingsberg, S.
    Wilson, H.
    Jordan, R.
    Johna, L.
    Revicki, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S403 - S404
  • [7] BREMELANOTIDE IS SAFE AND WELL-TOLERATED IN PREMENOPAUSAL WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD): SAFETY RESULTS FROM THE RECONNECT STUDIES
    Kroll, Robin
    Lucas, Johna
    JOURNAL OF WOMENS HEALTH, 2017, 26 (04) : A36 - A37
  • [8] ELEMENTS OF DESIRE QUESTIONNAIRE ASSESSMENT OF BREMELANOTIDE EFFICACY FOR HYPOACTIVE SEXUAL DESIRE DISORDER IN THE RECONNECT STUDY
    Revicki, D.
    Althof, S.
    DeRogatis, L.
    Kingsberg, S.
    Wilson, H.
    Jordan, R.
    Lucas, J.
    JOURNAL OF SEXUAL MEDICINE, 2018, 15 (06): : S99 - S99
  • [9] Bremelanotide for Hypoactive Sexual Desire Disorder in the RECONNECT Studies: Analysis of Baseline Arousal Subgroups
    Kingsberg, Sheryl
    Clayton, Anita
    Simon, James
    Jordan, Robert
    Lucas, Johna
    Williams, Laura
    Krop, Julie
    JOURNAL OF WOMENS HEALTH, 2019, 28 (06) : 22 - 22
  • [10] CONVERSATIONS WITH PARTICIPANTS IN THE RECONNECT STUDIES ABOUT THEIR EXPERIENCES WITH BREMELANOTIDE FOR TREATMENT OF HYPOACTIVE SEXUAL DESIRE DISORDER
    Koochaki, P.
    Revicki, D.
    Wilson, H.
    Pokrzywinsiki, R.
    Jordan, R.
    Lucas, J.
    Williams, L.
    Krop, J.
    JOURNAL OF SEXUAL MEDICINE, 2019, 16 (04): : S75 - S75
12345